I see a channel on the weekly with significant touches top and bottom. RSI is oversold and ready to move up, also the MACD looks to be turning up. Bullish divergence ... Great risk to reward... One to watch?
Looks like GWPH broke from the wedge and now retested the break out. Should be a low risk BUY here. Shoudn't go back into the wedge again.
Double bottom in an uptrend: - The double bottom looks like the letter "W". The twice-touched low is considered a support level. - The advance of the first bottom should be a drop of 10% to 20%, then the second bottom should form within 3% to 4% of the previous low, and volume on the ensuing advance should increase. - The double bottom pattern always follows a...
I got in at $3.66. Been in and out, trying to sell the rallies and buy the dip. It has been an interesting ride with some extreme gains. Needless to say that my position is bullish. So... what's next? My play with ZYNE is aimed at the CBD legislation that is expected at around October this year. ZYNE has many good patents, ready to market, and once CBD as an...
Urg.. tradingview decided to hide a lot of my previous idea because I didn't go pro, what a scam. If you like my charts and would like to support me going pro for $12.95, please msg me so i can keep sending out these ideas weekly. TradingView Open position at $182 Stop loss at $180 Take profit at $187 Why this play? Gwph had a pretty good earning but got...
It would seem that ZYNE got a bit ahead of itself. We were very extended on 26, 29 and 30 April, and finally saw some healthy consolidation with an initial 5% pull back. SPY was making ripples yesterday, and probably added much to panic reaction, more than 20% down. I bought that dip with much gratitude, and relished when buying pressure forced her back up to...
practice either way, long on it
Zynerba is one of my favourite biopharma stocks. I've played her from $3.88 up to $5.22, then sold when I saw that the hype was temporarily over. I didn't want to go long ZYNE, because biopharma is some scary stuff. When they presented failed trials earlier, the stock plunged 53%. On the other hand, when a trial succeeds, and a medicine can be filed and prepped...
Still in this short. Jumped in after the Weekly SFP of ATH. I think price reverses here and fills the gap to demand.
GWPH looks like it could have a at least a nice retracement at a worst case scneario and a juicy trade at a better scneario if the S&P does have a bit of a crash. I will be shorting this at current price and taking profit at green, I would like to re add at my elliot wave idea, lets see how this one ends up :)
Hit the strongest support area on the chart
Dear Traders, A little update on the GTEC stock. Our MACD shows us a Bullish Continuing Divergence, which is a bullish sign. This combined with the 200 ema being close, I'm expecting a bounce off from that 200 ema located at 1.08$. This might be a very good entry point in my opinion, but, if you are entering I would choose your stoploss carefully. I'm saying...
Dear Traders, GWPH, also known as GGW Pharmaceuticals plc (GWPH), has been following its bullish Channel pretty well. Thos I don't really know if im Bullish or Berish for now. We have good volume, we are in a bullish channel, but we are under the 1H 55 ema (Blue line). If resistance at the 55 ema holds, we will see a bit more retracing, but if we succeed in...